Intervention not reported
Serious adverse events up to day 45 · non‐hospitalised adults with mild COVID‐19
The intervention showed no clear difference in serious adverse events up to day 45 (low certainty).
1 finding from 1 review
- Antiplatelet agents for the treatment of adults with COVID‐19 2023 · Cochrane Headline outcomes onlyPeto OR 1 [0.6, 1.64]1 study · 3881 participantsLow